Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improvement of Symptoms After Removal of the Essure® Contraceptive Implant
NCT06355713Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Feb 2025
- Primary completion
- Apr 2032
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Percentage of patients with improvement in symptoms at 2 months. Started Feb 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06355713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355713.